Literature DB >> 27016968

Surgical Training and the Early Specialization Program: Analysis of a National Program.

Mary E Klingensmith1, John R Potts2, Walter H Merrill3, Timothy J Eberlein4, Robert S Rhodes5, Stanley W Ashley6, R James Valentine3, John G Hunter7, Steven C Stain8.   

Abstract

BACKGROUND: The Early Specialization Program (ESP) in surgery was designed by the American Board of Surgery, the American Board of Thoracic Surgery, and the Residency Review Committees for Surgery and Thoracic Surgery to allow surgical trainees dual certification in general surgery (GS) and either vascular surgery (VS) or cardiothoracic surgery (CTS) after 6 to 7 years of training. After more than 10 years' experience, this analysis was undertaken to evaluate efficacy. STUDY
DESIGN: American Board of Surgery and American Board of Thoracic Surgery records of VS and CTS ESP trainees were queried to evaluate qualifying exam and certifying exam performance. Case logs were examined and compared with contemporaneous non-ESP trainees. Opinions of programs directors of GS, VS, and CTS and ESP participants were solicited via survey.
RESULTS: Twenty-six CTS ESP residents have completed training at 10 programs and 16 VS ESP at 6 programs. First-time pass rates on American Board of Surgery qualifying and certifying exams were superior to time-matched peers; greater success in specialty specific examinations was also found. Trainees met required case minimums for GS despite shortened time in GS. By survey, 85% of programs directors endorsed satisfaction with ESP, and 90% endorsed graduate readiness for independent practice. Early Specialization Program participants report increased mentorship and independence, greater competence for practice, and overall satisfaction with ESP.
CONCLUSIONS: Individuals in ESP programs in VS and CTS were successful in passing GS and specialty exams and achieving required operative cases, despite an accelerated training track. Programs directors and participants report satisfaction with the training and confidence that ESP graduates are prepared for independent practice. This documented success supports ESP training in any surgical subspecialty, including comprehensive GS.
Copyright © 2016 American College of Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27016968     DOI: 10.1016/j.jamcollsurg.2015.12.035

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  6 in total

1.  Interim Analysis of a Prospective Multi-Institutional Study of Surgery Resident Experience with Flexibility in Surgical Training.

Authors:  Darren R Cullinan; Paul E Wise; Keith A Delman; John R Potts; Michael M Awad; Timothy J Eberlein; Mary E Klingensmith
Journal:  J Am Coll Surg       Date:  2018-01-05       Impact factor: 6.113

2.  Resident Operative Experience in Hepatopancreatobiliary Surgery: Exposing the Divide.

Authors:  Alexander R Cortez; Leah K Winer; Gianna D Katsaros; Al-Faraaz Kassam; Shimul A Shah; Tayyab S Diwan; R Cutler Quillin
Journal:  J Gastrointest Surg       Date:  2019-04-22       Impact factor: 3.452

3.  CORR Insights®: Are Recently Trained Tumor Fellows Performing Less Tumor Surgery? An Analysis of 10 Years of the ABOS Part II Database.

Authors:  Herbert S Schwartz
Journal:  Clin Orthop Relat Res       Date:  2016-10-26       Impact factor: 4.176

4.  Program Director Perceptions of Subspecialty Tracking in Obstetrics and Gynecology Residency.

Authors:  Eduardo Hariton; Taylor S Freret; Roni Nitecki; Emily Hinchcliff; Amy Stagg
Journal:  J Grad Med Educ       Date:  2018-12

5.  Commentary: The Integrated 6-Year Program and Early Specialization Program provide attractive pathways to train in cardiothoracic surgery.

Authors:  Spencer J Melby
Journal:  JTCVS Open       Date:  2021-01-30

6.  Comparison of the effects of coronary artery anastomosis training between senior and junior surgeons.

Authors:  Bo Li; Xiaokang Luo; Lei Qi; Dong Zhang; Fuliang Luo; Bin Li; Yue Tang
Journal:  Anatol J Cardiol       Date:  2020-09       Impact factor: 1.596

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.